GENENTECH GROWTH HORMONE SALES FORCE RETRAINING TO BEGIN IN 1997 AS PART OF CORRECTION ACTION PROGRAM STEMMING FROM AD DIVISION LETTER ON PROTROPIN

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".